Denmark's Novo Nordisk's Vikrant Shrotriya, India managing director and corporate vice-president said that the company is working toward launching its once-a-week insulin, Icodec, in India by mid-2025. Introducing anti-obesity drugs and medicines for diabetes, which induce weight loss, such as Wegovy and Ozempic made by Novo Nordisk is also on...